Carlsmed (CARL) Other Non-Current Liabilities (2024 - 2026)

Carlsmed's (CARL) quarterly Other Non-Current Liabilities came in at $327000.0 in Q1 2026, up 5.83% on a QoQ basis from $309000.0 in Q4 2025.

Carlsmed (CARL) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

Carlsmed (CARL) has 3 years of Other Non-Current Liabilities data on file, last reported at $327000.0 in Q1 2026.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $327000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $327000.0 (changed N/A YoY) and the FY2025 annual result came in at $309000.0, up 39.19% from the prior year.
Other Non-Current Liabilities advanced to $327000.0 in Q1 2026, from $309000.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $727000.0 in Q2 2025 to a low of $222000.0 in Q4 2024.
A 3-year average of $375000.0 and a median of $309000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
The widest YoY moves for Other Non-Current Liabilities: up 39.19% in 2025, down 39.19% in 2025.
Tracing CARL's Other Non-Current Liabilities over 3 years: stood at $222000.0 in 2024, then soared by 39.19% to $309000.0 in 2025, then gained by 5.83% to $327000.0 in 2026.
The last three Other Non-Current Liabilities figures came in at $327000.0 (Q1 2026), $309000.0 (Q4 2025), and $290000.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Carlsmed	389.87 Mn	276.57 Mn	14.54 Mn

Download Data